14 reports

Its Cardiovascular and Neuromodulation Products segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movemen

  • Immunodiagnostics
  • World
  • Forecast
  • Alere Inc.
  • Danaher Corporation

This includes blood, plasma, and CSF biomarkers for Alzheimer' s disease and chronic pain.

  • Immunodiagnostics
  • North America
  • United States
  • World
  • Market Size

IN NEUROMODULATION, STRONG DOUBLEDIGIT GROWTH WAS LED BY SEVERAL RECENTLY LAUNCHED PRODUCTS FOR THE TREATMENT OF CHRONIC PAIN AND MOVEMENT DISORDERS.

  • Clinical Trial
  • Hormone
  • Immunodiagnostics
  • Medical Device
  • Siemens Healthcare GmbH

one of the world' s leading providers of company operational data and strategic analysis, providing detailed information on tens of thousands of companies globally.

  • Biomarker
  • Cardiovascular Disease
  • Chronic Disease
  • Immunodiagnostics
  • Firalis SAS

In Neuromodulation, strong doubledigit growth was led by several recently launched products for the treatment of chronic pain and movement disorders.

  • Drug Development
  • Hormone
  • Immunodiagnostics
  • Vitamin
  • Roche Group

In Neuromodulation, strong doubledigit growth was led by several recently launched products for the treatment of chronic pain and movement disorders.

  • Biomarker
  • Biotech Diagnostics
  • Clinical Trial
  • Immunodiagnostics
  • Abbott

In Neuromodulation, strong doubledigit growth was led by several recently launched products for the treatment of chronic pain and movement disorders.

  • Clinical Trial
  • Immunodiagnostics
  • In Vitro Diagnostic Reagent
  • In Vitro Diagnostics
  • Novartis AG

In Neuromodulation, strong doubledigit growth was led by several recently launched products for the treatment of chronic pain and movement disorders.

  • Clinical Trial
  • Hepatitis
  • Hepatitis Testing
  • Immunodiagnostics
  • Abbott

In Neuromodulation, strong doubledigit growth was led by several recently launched products for the treatment of chronic pain and movement disorders.

  • Clinical Trial
  • Hormone
  • Immunodiagnostics
  • Medical Biotechnology
  • Siemens Healthcare GmbH

IN SPITE OF THE TOLL OPIOIDS HAVE TAKEN, HOWEVER, THERE ARE MANY SCENARIOS IN WHICH THESE DRUGS ARE STILL THE MOST EFFECTIVE TREATMENT FOR PAIN, SUCH AS AFTER SURGERY OR IN THE CASE OF PATIENTS WITH DEBILITATING CHRONIC PAIN.

  • Clinical Trial
  • HPV Testing
  • Immunodiagnostics
  • Sexually Transmitted Disease
  • ValiRx Plc

Tanezumab (PF-##) -- In June 2017, Pfizer and Eli Lilly and Company (Lilly) announced that the FDA granted Fast Track designation for tanezumab for the treatment of chronic pain in patients with osteoarthritis and chronic low back pain.

  • Clinical Trial
  • Healthcare
  • Immunodiagnostics
  • United States
  • Pfizer Inc.

In Neuromodulation, strong double-digit growth was led by several recently launched products for the treatment of chronic pain and movement disorders.

  • Clinical Trial
  • Hepatitis
  • Immunodiagnostics
  • Molecular Diagnostics
  • bioMerieux S.A.

IN NEUROMODULATION, STRONG DOUBLE-DIGIT GROWTH WAS LED BY SEVERAL RECENTLY LAUNCHED PRODUCTS FOR THE TREATMENT OF CHRONIC PAIN AND MOVEMENT DISORDERS.

  • Clinical Trial
  • Immunodiagnostics
  • Australia
  • Company
  • Company Financials

ALS GENETIC MARKER TEST PRODUCT OVERVIEW TABLE ##: ALS GENETIC MARKER TEST - PRODUCT STATUS TABLE ##: ALS GENETIC MARKER TEST - PRODUCT DESCRIPTION DIAGNOSTIC TEST - PELVIC PAIN SYNDROME PRODUCT OVERVIEW TABLE ##: DIAGNOSTIC TEST - PELVIC PAIN SYNDROME - PRODUCT STATUS TABLE ##

  • Autoimmune Disease
  • Clinical Trial
  • Immunodiagnostics
  • Neurological Disorder
  • Phadia Group